Treatments
534 articles
Study Reveals Molecular Differences in Young-Onset Pancreatic Cancer
There has been a notable increase in cases of young onset pancreatic cancer. Dr. Jashodeep Datta and team are exploring why this is happening.
Proud to be Living with Pancreatic Cancer
Paul Suntup is a long-term survivor living with recurring pancreatic cancer. He tells other patients that they too can survive this disease.
New FDA Approval Brings More Treatment Options in Metastatic Disease
The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.
I Wanted Immunotherapy!
When Daniel Miller was diagnosed with pancreatic cancer he knew he didn’t want chemotherapy—he wanted immunotherapy!
You Can Win This Fight
Rachel Moreno credits long-term survivor status to her choice to move to her son’s in Michigan for treatment, where she found a doctor and a clinical trial.
I’m Going to Beat This
Amy Zaterman is a long-term survivor who relied on her mother for support during treatment for stage IV pancreatic neuroendocrine cancer.
You’ll Get Through It
Margie Goldsmith has faced pancreatic cancer three times, and each time she has used her positive attitude to help her through treatment.
Surviving and Thriving
When long-term survivor Chris Joseph found out his tumor had a specific defect it changed his treatment plan.
New Immunotherapy Strategy Aimed at High-Risk Population
Dr. Neeha Zaidi is the lead investigator of an immunotherapy trial using a vaccine for people at high risk for pancreatic cancer.
Two New Immunotherapy Trials Aim to Make Therapy More Effective
Two clinical trials in the Lustgarten Foundation’s Clinical Accelerator are testing different combinations of immunotherapy.
Standing on the Shoulders of Giants
When long-term survivor Tom Dinwiddie was diagnosed with stage IV pancreatic neuroendocrine cancer he found doctors willing to treat him.
AACR Annual Meeting 2021 Highlights
Let’s Win and the Lustgarten Foundation bring you the pancreatic cancer research highlights of the 2021 AACR Annual Meeting,
RNA Precision Trial for Pancreatic Cancer Opens At Columbia
Dr. Andrea Califano leads a precision oncology clinical trial of the OncoTreat platform, which looks at proteins to determine treatment.
Targeting Mutant KRAS with Immunotherapy
Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.
New Study Combines Checkpoint Inhibitors with Radiation Therapy to Boost Immune Response
Dr. Theodore Hong combines checkpoint inhibitors–a type of immunotherapy–with radiation to boost the immune system in pancreatic cancer treatment.